New Rhein Healthcare Investors, LLC — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Neuraptive TherapeuticsDec 2018SEC filinghigh confidence
BiotechLouisville, US
David Jackson(Executive Officer, Director)Gino DiSciullo(Director)Randy Hubbell(Director)
Board seatGreg ParekhIvan Gergel· per SEC Form D · $38.1M raise · filed Oct 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.